Landry D W, Levin H R, Gallant E M, Ashton R C, Seo S, D'Alessandro D, Oz M C, Oliver J A
Department of Medicine, Columbia University, College of Physicians & Surgeons, New York, NY 10032, USA.
Circulation. 1997 Mar 4;95(5):1122-5. doi: 10.1161/01.cir.95.5.1122.
The hypotension of septic shock is due to systemic vasodilation. On the basis of a clinical observation, we investigated the possibility that a deficiency in vasopressin contributes to the vasodilation of septic shock.
In 19 patients with vasodilatory septic shock (systolic arterial pressure [SAP] of 92 +/- 2 mm Hg [mean +/- SE], cardiac output [CO] of 6.8 +/- 0.7 L/min) who were receiving catecholamines, plasma vasopressin averaged 3.1 +/- 1.0 pg/mL. In 12 patients with cardiogenic shock (SAP, 99 +/- 7 mm Hg; CO, 3.5 +/- 0.9 L/min) who were also receiving catecholamines, it averaged 22.7 +/- 2.2 pg/mL (P < .001). A constant infusion of exogenous vasopressin to 2 patients with septic shock resulted in the expected plasma concentration, indicating that catabolism of vasopressin is not increased in this condition. Although vasopressin is a weak pressor in normal subjects, its administration at 0.04 U/min to 10 patients with septic shock who were receiving catecholamines increased arterial pressure (systolic/diastolic) from 92/52 to 146/66 mm Hg (P < .001/P < .05) due to peripheral vasoconstriction (systemic vascular resistance increased from 644 to 1187 dyne.s/cm5; P < .001). Furthermore, in 6 patients with septic shock who were receiving vasopressin as the sole pressor, vasopressin withdrawal resulted in hypotension (SAP, 83 +/- 3 mm Hg), and vasopressin administration at 0.01 U/min, which resulted in a plasma concentration (approximately 30 pg/mL) expected for the level of hypotension, increased SAP from 83 to 115 mm Hg (P < .01).
Vasopressin plasma levels are inappropriately low in vasodilatory shock, most likely because of impaired baroreflex-mediated secretion. The deficiency in vasopressin contributes to the hypotension of vasodilatory septic shock.
感染性休克的低血压是由于全身血管扩张所致。基于一项临床观察,我们研究了血管升压素缺乏导致感染性休克血管扩张的可能性。
19例接受儿茶酚胺治疗的血管扩张性感染性休克患者(收缩压[SAP]为92±2mmHg[平均值±标准误],心输出量[CO]为6.8±0.7L/min),血浆血管升压素平均为3.1±1.0pg/mL。12例同样接受儿茶酚胺治疗的心源性休克患者(SAP为99±7mmHg;CO为3.5±0.9L/min),其血浆血管升压素平均为22.7±2.2pg/mL(P<0.001)。持续向2例感染性休克患者输注外源性血管升压素,使其达到预期的血浆浓度,表明在这种情况下血管升压素的分解代谢并未增加。尽管血管升压素在正常受试者中是一种较弱的升压剂,但以0.04U/min的速度给予10例接受儿茶酚胺治疗的感染性休克患者,由于外周血管收缩(全身血管阻力从644增加到1187达因·秒/厘米⁵;P<0.001),动脉压(收缩压/舒张压)从92/52mmHg升高到146/66mmHg(P<0.001/P<0.05)。此外,在6例仅接受血管升压素作为升压剂的感染性休克患者中,停用血管升压素导致低血压(SAP为83±3mmHg),而以0.01U/min的速度给予血管升压素,使其血浆浓度达到低血压水平预期的浓度(约30pg/mL),则使SAP从83mmHg升高到115mmHg(P<0.01)。
血管扩张性休克时血浆血管升压素水平异常低下,很可能是由于压力反射介导的分泌受损所致。血管升压素缺乏导致血管扩张性感染性休克的低血压。